Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cohen Gloria VirginiafiledCriticalCohen Gloria Virginia
Priority to ARP980100276priorityCriticalpatent/AR011559A1/es
Publication of AR011559A1publicationCriticalpatent/AR011559A1/es
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
La composicion del producto propuesto (cloruro de potasio: 75%, ácido glutámico 10%, glutamato monopotásico 10% carbonato de magnesio 2,5%, fosfatotricálcico 2,5%) lo hace apto para el consumo humano en todos los casos donde estácontraindica do la ingesta de cation sodio. La preparacion propuesta noposee las características de rechazo comunes a los demás preparados que se ofrecen.
ARP9801002761998-01-221998-01-22Sustituto de la sal de mesa en base a sales de potasio
AR011559A1
(es)
5-fluorobenzonitrile derivatives and pharmacologically acceptable acid addition salts thereof for increasing the lean meat to fat ratio,and/or enhancing the growth rate of warm-blooded animals
Feste zusammensetzungen für orale verabreichung die nicht-hygroskopische salze von l-carnitin- oder alkanoyl-l-carnitin mit 2-aminosulfonsäure enthalten